Compound Detail
CHEMBL5273985
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5273985 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | ALFPWDIULHLHJE-UHFFFAOYSA-N |
1
Targets
2
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
465.6
MW (Da)
5.35
ALogP
7
HBA
2
HBD
90.3
PSA (Ų)
0.41
QED
1
Ro5 Violations
9
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 6.14
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Nuclear receptor subfamily 1 group I member 2 CHEMBL3401 | IC50 | 6.14 | 5.775 | 730.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Nuclear receptor subfamily 1 group I member 2 | IC50 | = | 730.0 | nM | 6.14 | Inhibition of BODIPY FL vindoline binding to recombinant human GST-tagged PXR LB... | 36480704 |
| Nuclear receptor subfamily 1 group I member 2 | IC50 | = | 3900.0 | nM | 5.41 | Antagonist activity at human PXR in human HepG2 cells co-expressing luciferase g... | 36480704 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 36480704 | 10.1021/acs.jmedchem.2c01640 | Nuclear receptor subfamily 1 group I member 2 | 6 |
Data from ChEMBL 36 via Core Engine